These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27900818)

  • 1. Healthcare Costs Reduced After Incorporating the Results of the American College of Surgeons Oncology Group Z0011 Trial into Clinical Practice.
    Fillion MM; Glass KE; Hayek J; Wehr A; Phillips G; Terando A; Agnese DM
    Breast J; 2017 May; 23(3):275-281. PubMed ID: 27900818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic implications of ACOSOG Z0011 trial application into clinical practice at the European Institute of Oncology.
    Mattar D; Di Filippo A; Invento A; Radice D; Burcuta M; Bagnardi V; Magnoni F; Santomauro G; Corso G; Mazzarol G; Viale G; Sacchini V; Galimberti V; Veronesi P; Intra M
    Eur J Surg Oncol; 2021 Oct; 47(10):2499-2505. PubMed ID: 34172359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.
    Lombardi A; Nigri G; Maggi S; Stanzani G; Vitale V; Vecchione A; Nania A; Amanti C
    Surgeon; 2018 Aug; 16(4):232-236. PubMed ID: 29329752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel Lymph Node Frozen-Section Utilization Declines After Publication of American College of Surgeons Oncology Group Z0011 Trial Results With No Change in Subsequent Surgery for Axillary Lymph Node Dissection.
    Jorns JM; Kidwell KM
    Am J Clin Pathol; 2016 Jul; 146(1):57-66. PubMed ID: 27373347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis.
    Caretta-Weyer H; Greenberg CG; Wilke LG; Weiss J; LoConte NK; Decker M; Steffens NM; Smith MA; Neuman HB
    Ann Surg Oncol; 2013 Dec; 20(13):4145-52. PubMed ID: 23959051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the axilla: has Z0011 had an impact?
    Joyce DP; Lowery AJ; McGrath-Soo LB; Downey E; Kelly L; O'Donoghue GT; Barry M; Hill AD
    Ir J Med Sci; 2016 Feb; 185(1):145-9. PubMed ID: 25595827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of ACOSOG Z0011 criteria reduces perioperative costs.
    Camp MS; Greenup RA; Taghian A; Coopey SB; Specht M; Gadd M; Hughes K; Smith BL
    Ann Surg Oncol; 2013 Mar; 20(3):836-41. PubMed ID: 23010735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice.
    Weiss A; Mittendorf EA; DeSnyder SM; Hwang RF; Bea V; Bedrosian I; Hoffman K; Adrade B; Sahin AA; Kuerer HM; Hunt KK; Caudle AS
    Clin Breast Cancer; 2018 Aug; 18(4):276-281. PubMed ID: 29100726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of omission of axillary dissection on adjuvant therapy in patients with metastatic sentinel lymph nodes according to the ACOSOG Z0011 criteria].
    Roosen A; Lousquy R; Bricou A; Delpech Y; Selz J; Le Maignan C; Bousquet G; Winterman S; Zelek L; Barranger E
    Gynecol Obstet Fertil; 2014 Jun; 42(6):409-14. PubMed ID: 24861437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?
    Robinson KA; Pockaj BA; Wasif N; Kaufman K; Gray RJ
    Am J Surg; 2014 Dec; 208(6):1060-4; discussion 1063-4. PubMed ID: 25312842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.
    Costaz H; Boulle D; Bertaut A; Rouffiac M; Beltjens F; Desmoulins I; Peignaux K; Ladoire S; Causeret S; Loustalot C; Padeano MM; Vincent L; Jankowski C; Arnould L; Coutant C
    Bull Cancer; 2022 Mar; 109(3):268-279. PubMed ID: 34838310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Mann JM; Wu X; Christos P; Nagar H
    Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in Frozen Section Diagnosis for Axillary Sentinel Lymph Nodes as a Result of the American College of Surgeons Oncology Group Z0011 Trial.
    Bishop JA; Sun J; Ajkay N; Sanders MA
    Arch Pathol Lab Med; 2016 Aug; 140(8):830-5. PubMed ID: 26716950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond.
    Gatzemeier W; Mann GB
    Breast; 2013 Jun; 22(3):211-6. PubMed ID: 23478200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.
    Ong CT; Thomas SM; Blitzblau RC; Fayanju OM; Park TS; Plichta JK; Rosenberger LH; Hyslop T; Shelley Hwang E; Greenup RA
    Ann Surg Oncol; 2017 Nov; 24(12):3559-3566. PubMed ID: 28879416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.
    Caudle AS; Hunt KK; Tucker SL; Hoffman K; Gainer SM; Lucci A; Kuerer HM; Meric-Bernstam F; Shah R; Babiera GV; Sahin AA; Mittendorf EA
    Ann Surg Oncol; 2012 Oct; 19(10):3144-51. PubMed ID: 22847123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in utilization of axillary dissection in women with invasive breast cancer and sentinel node metastasis after the ACOSOG Z0011 trial.
    Tseng J; Alban RF; Siegel E; Chung A; Giuliano AE; Amersi FF
    Breast J; 2021 Mar; 27(3):216-221. PubMed ID: 33586201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study.
    Delpech Y; Bricou A; Lousquy R; Hudry D; Jankowski C; Willecocq C; Thoury A; Loustalot C; Coutant C; Barranger E
    Ann Surg Oncol; 2013 Aug; 20(8):2556-61. PubMed ID: 23456432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients.
    Verheuvel NC; Voogd AC; Tjan-Heijnen VC; Roumen RM
    Eur J Surg Oncol; 2016 Aug; 42(8):1162-8. PubMed ID: 27265036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.